期刊文献+

喹硫平与氯丙嗪治疗分裂症的抑郁症状疗效比较

下载PDF
导出
摘要 目的探讨喹硫平与氯丙嗪治疗分裂症伴有抑郁症状患者的疗效。方法将符合中国精神障碍分类与诊断标准第3版诊断标准的64例分裂症伴有抑郁症状患者,随机分为喹硫平组与氯丙嗪组,疗程6周,将汉密尔顿抑郁量表(HAMD17项)的减分率作为疗效评定标准,分别测评治疗前和治疗时1、2、4、6周总分值的变化情况。结果喹硫平组治疗后各周HAMD评分较治疗前有显著下降;氯丙嗪组治疗后4周评分较治疗前有所下降;两组比较喹硫平组治疗分裂症的抑郁症状疗效较氯丙嗪组显著较好。
出处 《齐齐哈尔医学院学报》 2010年第3期395-395,共1页 Journal of Qiqihar Medical University
  • 相关文献

参考文献1

二级参考文献15

  • 1Yatham LN, Kennedy SH, Odonovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies [ J ]. Bipolar Disord, 2005,7 ( Suppl. 3 ) : 5 -69.
  • 2Hou C ,Jla F, Liu Y, et al. CSF serotonin ,5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder[ J ]. Brain Res ,2006,1095 : 154-158.
  • 3Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety [ J]. J. Clin Psychiatry ,2005,66( Suppl. 8 ) :30-40.
  • 4Mintyn MA, Sheline YI, Moerlein SM, et al. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [ 18F] altanserin positron emission tomography [ J ]. Binl Psychiatry ,2004,55:217-224.
  • 5Yatham LN, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression : potential mechanisms of action [ J ]. J. Clin Psychiatry ,2005,66( Suppl. 5 ) :40-48.
  • 6Meyer JH, Mcneely HE, Sagrati S, et al. Elevated putamen D ( 2 ) receptor binding potential in major depression with motor retardation : an [ 11C ] raclopride positron emission tomography study [ J ]. Am J Psychiatry ,2006,163:594-602.
  • 7Davies MA, Setola V, Strachan RT, et al. Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies [ J ]. Pharmacogenomics J, 2006,6:42-51.
  • 8Goldstein JM. Quetiapine fumarate (Seroquel) :a new atypical antipsychotic I J]. Drugs Today, 1999,35 : 193-210.
  • 9Diehl D J, Gershon S. The role of dopamine in mood disorders[ J ]. Compr Psychiatry, 1992 33 : 115-120.
  • 10Krystal JH, Sanacora G, Blumberg H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments [ J ]. Mol Psychiatry,2002,7 ( Suppl. 1 ) -71-80.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部